mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.01 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.01 |